Home / Latest Reports / Rapid Test Market

Rapid Test Market by Basis of Contaminant and Technology - Global Industry Analysis & Forecast to 2027

Published On : June 2022 Pages : 180 Category: In-Vitro Diagnostics Report Code : HC063875

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Rapid Test Market by Basis of Contaminant (Mycotoxins, Allergens, Pathogens, Meat speciation, GMOs, Pesticides, Others) Technology (Spectroscopy-based, PCR-based, Chromatography-based, Immunoassay-based) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The rapid test is utilized for reliable and faster outcomes to guarantee food safety. Different contaminants, for example, pathogens, veterinary medications, preparing incited synthetic compounds, and so forth can cause infectious diseases and serious illness. The advancements utilized for the rapid test are immunoassay-based, chromatography-based, and so forth.

Drivers and Restraints

Developing demand for rapid test to test food products owing to expanding foodborne sickness and infectious maladies is the main consideration expected to fuel the development of the objective market in years to come. Furthermore, a rapid test is utilized to dispense with the danger of bacterial or microbial contamination brought about by pathogens, GMOs, meat speciation, allergens, and so forth and keep up the nature of the item. Expanding interest for rapid test advances inferable from the usage of stringent food safety guidelines is another factor foreseen to drive the development of the worldwide rapid test market.

Regional Insights

The rapid test market in North America is expected to represent major income share projected and contribution to keep up its predominance in the objective market in the following 10 years.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • ALS Limited
  • Intertek Group plc
  • Microbac Laboratories, Inc.
  • Eurofins Scientific SE
  • Bureau Veritas SA
  • SGS SA
  • Asurequality Ltd.
  • TÜV SÜD AG
  • Merieux Nutrisciences Corporation
  • Genetic Id Na Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Rapid Test Market, By Basis of Contaminant, Estimates and Forecast, 2017-2027 ($Million)

o    Mycotoxins

o    Allergens

o    Pathogens

o    Meat speciation

o    GMOs

o    Pesticides

o    Others

·         Rapid Test Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)

o    Spectroscopy-based

o    PCR-based

o    Chromatography-based

o    Immunoassay-based

·         Rapid Test Market, By Key Players

o    ALS Limited

o    Intertek Group plc

o    Microbac Laboratories, Inc.

o    Eurofins Scientific SE

o    Bureau Veritas SA

o    SGS SA

o    Asurequality Ltd.

o    TÜV SÜD AG

o    Merieux Nutrisciences Corporation

o    Genetic Id Na Inc.

·         Rapid Test Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Rapid Test Market, By Country

o    U.S. Rapid Test Market

o    Canada Rapid Test Market

o    Mexico Rapid Test Market

o    Europe

§  Europe Rapid Test Market, By Country

o    Germany Rapid Test Market

o    UK Rapid Test Market

o    France Rapid Test Market

o    Russia Rapid Test Market

o    Italy Rapid Test Market

o    Rest of Europe Rapid Test Market

o    Asia-Pacific

§  Asia-Pacific Rapid Test Market, By Country

o    China Rapid Test Market

o    Japan Rapid Test Market

o    South Korea Rapid Test Market

o    India Rapid Test Market

o    Southeast Asia Rapid Test Market

o    Rest of Asia-Pacific Rapid Test Market

o    South America

§  South America Rapid Test Market

o    Brazil Rapid Test Market

o    Argentina Rapid Test Market

o    Columbia Rapid Test Market

o    Rest of South America Rapid Test Market

o    Middle East and Africa

§  Middle East and Africa Rapid Test Market

o    Saudi Arabia Rapid Test Market

o    UAE Rapid Test Market

o    Egypt Rapid Test Market

o    Nigeria Rapid Test Market

o    South Africa Rapid Test Market

o    Rest of MEA Rapid Test Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Rapid Test  Market, By Basis Of Contaminant

5.1.     Introduction

5.2.     Global Rapid Test  Revenue and Market Share by Basis Of Contaminant (2017-2027)

5.2.1.  Global Rapid Test  Revenue and Revenue Share by Basis Of Contaminant (2017-2027)

5.3.     Mycotoxins

5.3.1.  Global Mycotoxins Revenue and Growth Rate (2017-2027)

5.4.     Allergens

5.4.1.  Global Allergens Revenue and Growth Rate (2017-2027)

5.5.     Pathogens

5.5.1.  Global Pathogens Revenue and Growth Rate (2017-2027)

5.6.     Meat speciation

5.6.1.  Global Meat speciation Revenue and Growth Rate (2017-2027)

5.7.     GMOs

5.7.1.  Global GMOs Revenue and Growth Rate (2017-2027)

5.8.     Pesticides

5.8.1.  Global Pesticides Revenue and Growth Rate (2017-2027)

5.9.     Others

5.9.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Rapid Test  Market, By Technology

6.1.     Introduction

6.2.     Global Rapid Test  Revenue and Market Share by Technology (2017-2027)

6.2.1.  Global Rapid Test  Revenue and Revenue Share by Technology (2017-2027)

6.3.     Spectroscopy-based

6.3.1.  Global Spectroscopy-based Revenue and Growth Rate (2017-2027)

6.4.     PCR-based

6.4.1.  Global PCR-based Revenue and Growth Rate (2017-2027)

6.5.     Chromatography-based

6.5.1.  Global Chromatography-based Revenue and Growth Rate (2017-2027)

6.6.     Immunoassay-based

6.6.1.  Global Immunoassay-based Revenue and Growth Rate (2017-2027)

7.       Rapid Test  Market, By Region

7.1.     Introduction

7.2.     Global Rapid Test  Revenue and Market Share by Regions

7.2.1.  Global Rapid Test  Revenue by Regions (2017-2027)

7.3.     North America Rapid Test  by Countries

7.3.1.  North America Rapid Test  Revenue and Growth Rate (2017-2027)

7.3.2.  North America Rapid Test  Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Rapid Test  by Countries

7.4.1.  Europe Rapid Test  Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Rapid Test  Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Rapid Test  by Countries

7.5.1.  Asia-Pacific Rapid Test  Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Rapid Test  Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Rapid Test  by Countries

7.6.1.  South America Rapid Test  Revenue and Growth Rate (2017-2027)

7.6.2.  South America Rapid Test  Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Rapid Test  by Countries

7.7.1.  Middle East and Africa Rapid Test  Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Rapid Test  Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     ALS Limited

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Intertek Group plc

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Microbac Laboratories, Inc.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Eurofins Scientific SE

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Bureau Veritas SA

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     SGS SA

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Asurequality Ltd.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     TÜV SÜD AG

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Merieux Nutrisciences Corporation

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Genetic Id Na Inc.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Rapid Test  Market Forecast (2017-2027)

9.1.     Global Rapid Test  Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Rapid Test  Market Forecast by Regions (2017-2027)

9.2.1.  North America Rapid Test  Market Forecast (2017-2027)

9.2.1.1.  United States Rapid Test  Market Forecast (2017-2027)

9.2.1.2.  Canada Rapid Test  Market Forecast (2017-2027)

9.2.1.3.  Mexico Rapid Test  Market Forecast (2017-2027)

9.2.2.  Europe Rapid Test  Market Forecast (2017-2027)

9.2.2.1.  Germany Rapid Test  Market Forecast (2017-2027)

9.2.2.2.  France Rapid Test  Market Forecast (2017-2027)

9.2.2.3.  UK Rapid Test  Market Forecast (2017-2027)

9.2.2.4.  Russia Rapid Test  Market Forecast (2017-2027)

9.2.2.5.  Italy Rapid Test  Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Rapid Test  Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Rapid Test  Market Forecast (2017-2027)

9.2.3.1.  China Rapid Test  Market Forecast (2017-2027)

9.2.3.2.  Japan Rapid Test  Market Forecast (2017-2027)

9.2.3.3.  Korea Rapid Test  Market Forecast (2017-2027)

9.2.3.4.  India Rapid Test  Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Rapid Test  Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Rapid Test  Market Forecast (2017-2027)

9.2.4.  South America Rapid Test  Market Forecast (2017-2027)

9.2.4.1.  Brazil Rapid Test  Market Forecast (2017-2027)

9.2.4.2.  Argentina Rapid Test  Market Forecast (2017-2027)

9.2.4.3.  Columbia Rapid Test  Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Rapid Test  Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Rapid Test  Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Rapid Test  Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Rapid Test  Market Forecast (2017-2027)

9.2.5.3.  Egypt Rapid Test  Market Forecast (2017-2027)

9.2.5.4.  Nigeria Rapid Test  Market Forecast (2017-2027)

9.2.5.5.  South Africa Rapid Test  Market Forecast (2017-2027)

9.2.5.6.  Turkey Rapid Test  Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Rapid Test  Market Forecast (2017-2027)

9.3.     Rapid Test  Market Forecast by Basis Of Contaminant (2017-2027)

9.3.1.  Rapid Test  Forecast by Basis Of Contaminant (2017-2027)

9.3.2.  Rapid Test  Market Share Forecast by Basis Of Contaminant (2017-2027)

9.4.     Rapid Test  Market Forecast by Technology (2017-2027)

9.4.1.  Rapid Test  Forecast by Technology (2017-2027)

9.4.2.  Rapid Test  Market Share Forecast by Technology (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Rapid Test Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Rapid Test Revenue and Revenue Share by Basis Of Contaminant (2017-2018)
Figure Global Mycotoxins Revenue and Growth Rate (2017-2018)
Figure Global Allergens Revenue and Growth Rate (2017-2018)
Figure Global Pathogens Revenue and Growth Rate (2017-2018)
Figure Global Meat speciation Revenue and Growth Rate (2017-2018)
Figure Global GMOs Revenue and Growth Rate (2017-2018)
Figure Global Pesticides Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Rapid Test Revenue and Revenue Share by Technology (2017-2018)
Figure Global Spectroscopy-based Revenue and Growth Rate (2017-2018)
Figure Global PCR-based Revenue and Growth Rate (2017-2018)
Figure Global Chromatography-based Revenue and Growth Rate (2017-2018)
Figure Global Immunoassay-based Revenue and Growth Rate (2017-2018)
Table Global Rapid Test Revenue by Regions (2017-2018)
Figure North America Rapid Test Growth Rate (2017-2018)
Figure North America Rapid Test Revenue and Growth Rate (2017-2018)
Figure North America Rapid Test by Countries (2017-2018)
Figure North America Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure United States Rapid Test Growth Rate (2017-2018)
Figure United States Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Rapid Test Growth Rate (2017-2018)
Figure Canada Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Rapid Test Growth Rate (2017-2018)
Figure Mexico Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Rapid Test Growth Rate (2017-2018)
Figure Europe Rapid Test Revenue and Growth Rate (2017-2018)
Figure Europe Rapid Test by Countries (2017-2018)
Figure Europe Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Germany Rapid Test Growth Rate (2017-2018)
Figure Germany Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Rapid Test Growth Rate (2017-2018)
Figure France Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Rapid Test Growth Rate (2017-2018)
Figure UK Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Rapid Test Growth Rate (2017-2018)
Figure Russia Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Rapid Test Growth Rate (2017-2018)
Figure Italy Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Rapid Test Growth Rate (2017-2018)
Figure Rest of Europe Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Rapid Test Growth Rate (2017-2018)
Figure Asia-Pacific Rapid Test Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Rapid Test by Countries (2017-2018)
Figure Asia-Pacific Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure China Rapid Test Growth Rate (2017-2018)
Figure China Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Rapid Test Growth Rate (2017-2018)
Figure Japan Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Rapid Test Growth Rate (2017-2018)
Figure Korea Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Rapid Test Growth Rate (2017-2018)
Figure India Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Rapid Test Growth Rate (2017-2018)
Figure Southeast Asia Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Rapid Test Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Rapid Test Growth Rate (2017-2018)
Figure South America Rapid Test Revenue and Growth Rate (2017-2018)
Figure South America Rapid Test by Countries (2017-2018)
Figure South America Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Rapid Test Growth Rate (2017-2018)
Figure Brazil Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Rapid Test Growth Rate (2017-2018)
Figure Argentina Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Rapid Test Growth Rate (2017-2018)
Figure Columbia Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Rapid Test Growth Rate (2017-2018)
Figure Rest of South America Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Rapid Test Growth Rate (2017-2018)
Figure Middle East and Africa Rapid Test Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Rapid Test by Countries (2017-2018)
Figure Middle East and Africa Rapid Test Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Rapid Test Growth Rate (2017-2018)
Figure Saudi Arabia Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Rapid Test Growth Rate (2017-2018)
Figure United Arab Emirates Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Rapid Test Growth Rate (2017-2018)
Figure Egypt Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Rapid Test Growth Rate (2017-2018)
Figure Nigeria Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Rapid Test Growth Rate (2017-2018)
Figure South Africa Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Rapid Test Growth Rate (2017-2018)
Figure Turkey Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Rapid Test Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Rapid Test Revenue (Millions USD) and Growth Rate (2017-2018)
Table ALS Limited Rapid Test Financial Overview
Table Intertek Group plc Rapid Test Financial Overview
Table Microbac Laboratories, Inc. Rapid Test Financial Overview
Table Eurofins Scientific SE Rapid Test Financial Overview
Table Bureau Veritas SA Rapid Test Financial Overview
Table SGS SA Rapid Test Financial Overview
Table Asurequality Ltd. Rapid Test Financial Overview
Table TÜV SÜD AG Rapid Test Financial Overview
Table Merieux Nutrisciences Corporation Rapid Test Financial Overview
Table Genetic Id Na Inc. Rapid Test Financial Overview
Figure Global Rapid Test Revenue (Millions USD) and Growth Rate (2018-2025)
Table Rapid Test Market Forecast by Regions (2018-2025)
Figure North America Rapid Test Market Forecast (2018-2025)
Figure United States Rapid Test Market Forecast (2018-2025)
Figure Canada Rapid Test Market Forecast (2018-2025)
Figure Mexico Rapid Test Market Forecast (2018-2025)
Figure Europe Rapid Test Market Forecast (2018-2025)
Figure Germany Rapid Test Market Forecast (2018-2025)
Figure France Rapid Test Market Forecast (2018-2025)
Figure UK Rapid Test Market Forecast (2018-2025)
Figure Russia Rapid Test Market Forecast (2018-2025)
Figure Italy Rapid Test Market Forecast (2018-2025)
Figure Rest of Europe Rapid Test Market Forecast (2018-2025)
Figure Asia-Pacific Rapid Test Market Forecast (2018-2025)
Figure China Rapid Test Market Forecast (2018-2025)
Figure Japan Rapid Test Market Forecast (2018-2025)
Figure Korea Rapid Test Market Forecast (2018-2025)
Figure India Rapid Test Market Forecast (2018-2025)
Figure Southeast Asia Rapid Test Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Rapid Test Market Forecast (2018-2025)
Figure South America Rapid Test Market Forecast (2018-2025)
Figure Brazil Rapid Test Market Forecast (2018-2025)
Figure Argentina Rapid Test Market Forecast (2018-2025)
Figure Columbia Rapid Test Market Forecast (2018-2025)
Figure Rest of South America Rapid Test Market Forecast (2018-2025)
Figure Middle East and Africa Rapid Test Market Forecast (2018-2025)
Figure Saudi Arabia Rapid Test Market Forecast (2018-2025)
Figure United Arab Emirates Rapid Test Market Forecast (2018-2025)
Figure Egypt Rapid Test Market Forecast (2018-2025)
Figure Nigeria Rapid Test Market Forecast (2018-2025)
Figure South Africa Rapid Test Market Forecast (2018-2025)
Figure Turkey Rapid Test Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Rapid Test Market Forecast (2018-2025)
Figure Global Rapid Test Forecast by Basis Of Contaminant (2018-2025)
Figure Global Rapid Test Market Share Forecast by Basis Of Contaminant (2018-2025)
Figure Global Rapid Test Forecast by Basis Of Contaminant (2018-2025)
Figure Global Rapid Test Forecast by Technology (2018-2025)
Figure Global Rapid Test Market Share Forecast by Technology (2018-2025)
Figure Global Rapid Test Forecast by Technology (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample